John Andres Net Worth

John Andres biography

John C. Andres J.D. serves as Independent Vice Chairman of the Board of the Company. He has over thirty years of experience in the medical device industry. Since April, 2004, Mr. Andres has been a private consultant, doing business through John C. Andres, LLC, specializing in patent/business strategy development and execution. He also is a partner of Hawk Healthcare, LLC, which provides strategic transaction management to private individuals and companies. In 2017, Mr. Andres joined the Longeviti Neuro Solutions, LLC Board of Directors which is developing cranial implant products for cranial reconstruction. In 2004, Mr. Andres helped found K2M, Inc. (KTWO) and from 2004 until 2010 served as a member of the Board of Directors of K2M, Inc. Prior to 2004, Mr. Andres held various legal and strategic business development positions at the Surgical Division of Tyco Healthcare Group, LLP, now Medtronic (NYSE: MDT) and its predecessor, United States Surgical Corporation. Before joining U.S. Surgical, Mr. Andres worked at the New York law firm of Morgan & Finnegan. He received his Associate of Applied Science degree from Rochester Institute of Technology, his Bachelor of Arts degree from Lehigh University and his Juris Doctor from Pace University School of Law. The Company believes Mr. Andres is qualified to serve as a director because of his extensive experience in patent and business strategy development and execution in the medical device industry.

What is the salary of John Andres?

As the Independent Vice Chairman of the Board of Apyx Medical, the total compensation of John Andres at Apyx Medical is $157,368. There are 9 executives at Apyx Medical getting paid more, with Charles Goodwin having the highest compensation of $1,945,260.

What's John Andres's mailing address?

John's mailing address filed with the SEC is C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER, FL, 33760.

Insiders trading at Apyx Medical

Over the last 6 years, insiders at Apyx Medical have traded over $0 worth of Apyx Medical stock and bought 97,836 units worth $253,260 . The most active insiders traders include Stavros G. Vizirgianakis, Charles D. Ii Goodwin y Moshe Citronowicz. On average, Apyx Medical executives and independent directors trade stock every 86 days with the average trade being worth of $18,719. The most recent stock trade was executed by Matthew C Hill on 13 August 2024, trading 5,336 units of APYX stock currently worth $6,030.

What does Apyx Medical do?

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market that allows surgeons to operate with precision and eliminate unintended tissue trauma. It also develops, manufactures, and sells energy generators, disposable hand piece subassemblies, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Apyx Medical executives and stock owners

Apyx Medical executives and other stock owners filed with the SEC include:

• Charles Goodwin,
  Chief Executive Officer, Director
• Todd Hornsby,
  Executive Vice President
• Moshe Citronowicz,
  Senior Vice President
• Tara Semb,
  Chief Financial Officer, Treasurer, Secretary
• Charles D. Goodwin II,
  Pres, CEO & Director
• Todd Hornsby,
  Exec. VP
• Tara H. Semb,
  CFO, Treasurer & Sec.
• Moshe Citronowicz,
  Sr. VP
• Lawrence Waldman,
  Lead Independent Director
• John Andres,
  Independent Vice Chairman of the Board
• Andrew Makrides,
  Independent Chairman of the Board
• Michael Geraghty,
  Independent Director
• Craig Swandal,
  Independent Director
• Minnie Baylor-Henry,
  Independent Director
• Wendy Lauren Levine,
  Director
• Matthew C Hill,
  Chief Financial Officer
• Stavros G. Vizirgianakis,
  Director